The ANO10 gene helps nerve cells, especially in the cerebellum, keep their internal membranes working normally. When it does not work properly, people can develop an inherited ataxia, with unsteady walking, poor coordination, slurred speech, and sometimes muscle cramps or seizures. Usually this happens when a person inherits a disease causing variant in both copies of the gene. Understanding this gene can help you make sense of why these balance and movement problems can run in families.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage activities in the body. Some genes provide the directions for building proteins, which are the cell’s working parts. Others mostly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they may also influence how you respond to food, stress, or medicines. More detail on this topic is available in the LearnHub.
Overview
ANO10Gene function
What if the gene works
The ANO10 gene helps cells keep membrane fats balanced, especially in the endoplasmic reticulum, a cell compartment that makes and processes proteins. This supports healthy nerve cell function and steady cell signaling.
Risk
What if the gene does not work
Variants in the ANO10 gene most often cause a recessive ataxia with worsening balance, coordination, and speech problems. Milder and more severe variants can influence when symptoms begin and whether nerve symptoms or seizures also appear.
Treatment
What does that mean for your treatment
No ANO10-specific treatment or drug selection approach is currently established. The ANO10 gene is being studied in inherited ataxia research, including whether coenzyme Q10 may help some people, but this has not become a guideline-based treatment.
Conditions associated with ANO10
Gene function
What if the gene works
Inside your cells, the ANO10 gene supports the healthy upkeep of internal membranes. Most of its protein works in the endoplasmic reticulum, a network that helps make and handle proteins and fats. Understanding ANO10 gene function helps explain how cells keep membrane fats balanced for everyday activity.
The ANO10 gene helps move phospholipids (membrane fats) from one side of a membrane to the other. This mixing process helps internal cell membranes stay balanced and able to change shape when needed.
Most ANO10 protein sits in the endoplasmic reticulum, the cell’s membrane network for making and handling proteins and fats. There it helps maintain a stable membrane environment for routine cell work.
Anoctamin 10 becomes more active when calcium levels inside the cell rise. This lets cells adjust membrane fat movement during normal signaling and transport.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help make up normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ANO10 gene can make the protein unstable, send it to the wrong place, or weaken its ability to move membrane fats, showing how ANO10 gene variants affect protein function. Some changes leave partial activity, while more disruptive variants can stop the protein from being made or working at all. In people with ataxia linked to the ANO10 gene, greater loss of function may be linked to earlier onset or more marked symptoms.
How variants are linked to conditions
Pathogenic variants in the ANO10 gene cause spinocerebellar ataxia, autosomal recessive type 10, so the link between ANO10 gene variants and spinocerebellar ataxia is well established. This inherited condition is mainly associated with gradually worsening balance and coordination problems, often with unsteady walking and slurred speech. Some people also have nerve symptoms, seizures, or mild thinking and memory changes.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ANO10, risk is mainly shaped by inheritance: people usually develop ANO10-related ataxia only if they inherit two changed copies, one from each parent. A family history of the condition, or parents who are related by blood, can raise the chance of carrying the same ANO10 change; beyond that, there is not enough evidence to say lifestyle or environmental factors clearly change risk.
Inheritance of ANO10 variants
ANO10-related conditions are inherited in an autosomal recessive pattern. In practical terms, how ANO10 variants are inherited usually means a child needs to receive one altered copy of the ANO10 gene from each parent to be affected. When both parents carry one variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child who inherits neither variant. Parents who are carriers usually do not have symptoms.
What does my ANO10 result mean for my family?
For families with a disease-causing change in the ANO10 gene, the pattern is usually recessive, which means close relatives may also be carriers even if they feel well. Brothers and sisters of an affected person may also have the condition or carry the same gene change. Parents are usually healthy carriers, and other relatives on both sides of the family may want to learn whether they carry it too.
Genetic information
Genetic testing
How you find out about variants
Finding changes in the ANO10 gene usually involves ANO10 genetic testing on a blood or saliva sample. A lab reads the gene’s DNA code and checks for variants by comparing it with a reference sequence. Results may show a benign variant, a disease causing variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider genetic testing for the ANO10 gene if you or a close relative has an unexplained inherited balance and coordination condition, especially with walking problems, slurred speech, shaky movements, or numbness in the feet and legs. Testing can help confirm whether ANO10-related ataxia is the cause.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and the kind of variant involved. Factors such as lifestyle, environment, age, and medical history also influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause side effects more easily in someone else. These differences are common and are one part of the reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way people respond to medicines. It focuses on links between genes and medications to help explain why the same treatment may work differently from one person to another. With many drugs, genes can influence how powerful a medicine’s effects are or how the body handles it. This information can support treatment decisions that are better informed and more individualized. More on this topic is available in the LearnHub.
Drugs influenced by the ANO10 gene
When should I seek medical advice?
At this time, there is no broadly confirmed evidence that changes in this gene meaningfully affect how medicines work, so any concerns about treatment, side effects, or new symptoms are best discussed with your doctor.
History
ANO10 entered the medical literature in the late 2000s as part of the anoctamin gene family, a group of related genes identified during broader efforts to map human genes linked to cell membranes. In recent decades, awareness of this gene’s role has grown. A major step came in the early 2010s, when researchers linked variants in the ANO10 gene to a form of inherited ataxia, a condition that affects balance and coordination. That finding helped connect earlier clinical descriptions of families with slowly progressive movement problems to a specific genetic cause. From these first observations, research expanded steadily, and ANO10 became part of the growing field of genes linked to cerebellar ataxia. Today, its history is mainly tied to that shift from describing symptoms to identifying an inherited explanation.